← All trials
NCT05789589
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 16, 2023
- Primary completion
- Oct 31, 2025
- Completion date
- Aug 31, 2027
- First posted
- Mar 29, 2023
- Last posted
- Dec 27, 2023
- Enrollment
- 46
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Baptist HealthLead sponsor
- Miami Cancer InstituteCollaborator
- Baptist HealthOverall official - principal investigator
- Cantex PharmaceuticalsCollaborator
- Baptist HealthOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.